A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Clinical trial NCT06092034 · RECRUITING
Trial details
- NCT number
- NCT06092034
- Sponsor
- Rocket Pharmaceuticals Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-05
- Primary completion
- 2028-04-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.